Sign In

Adam Rosenthal

CEO and Founder

Adam Rosenthal is the CEO and Founder of Star Therapeutics, a biotechnology company that aims to create life-changing therapies by exploring novel biology and targeting commonalities across multiple diseases.35 He founded the company in 2018.145 Rosenthal is also the co-founder and head of Vega Therapeutics and Electra Therapeutics, subsidiaries of Star Therapeutics.6

Rosenthal's previous experience includes:

  • Chief Business Officer at True North Therapeutics He raised over $140M in private financing and contributed to the company’s acquisition by Bioverativ for $825M.125
  • Vice President, Head of Corporate Development at iPierian He contributed to the company’s acquisition by Bristol-Myers Squibb for $725M.125
  • Project Leader at the Boston Consulting Group125

Rosenthal has multiple degrees from the Massachusetts Institute of Technology (MIT), including BS degrees in Electrical Engineering and Brain and Cognitive Science, and an MEng degree in Electrical Engineering and Computer Science. He also holds a PhD in Biomedical Engineering from MIT and Harvard.15

Rosenthal is scheduled to present an overview of Star Therapeutics and its lead drug candidate, VGA039, at the 43rd annual J.P. Morgan Healthcare Conference on January 14, 2025.7

Highlights

Leadership
Leadership
Adam Rosenthal
Adam Rosenthal

Related Questions

What are the main therapeutic areas Star Therapeutics is focusing on?
How did Adam Rosenthal's experience at True North Therapeutics influence his approach at Star Therapeutics?
What are some of the key milestones achieved by Star Therapeutics under Adam Rosenthal's leadership?
How does Star Therapeutics differentiate itself from other biotech companies?
What are the future plans and goals for Star Therapeutics under Adam Rosenthal's leadership?
Adam Rosenthal
Adam Rosenthal, photo 1
Adam Rosenthal, photo 2
Add to my network

Location

San Francisco Bay Area